Advertisement

International Journal of Clinical Oncology

, Volume 21, Issue 3, pp 419–434 | Cite as

Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms

  • Yasuhiko EbinaEmail author
  • Hidetaka Katabuchi
  • Mikio Mikami
  • Satoru Nagase
  • Nobuo Yaegashi
  • Yasuhiro Udagawa
  • Hidenori Kato
  • Kaneyuki Kubushiro
  • Kiyoshi Takamatsu
  • Kazuhiko Ino
  • Hiroyuki Yoshikawa
Special Article

Abstract

The third version of the Japan Society of Gynecologic Oncology guidelines for the treatment of uterine body neoplasms was published in 2013. The guidelines comprise nine chapters and nine algorithms. Each chapter includes a clinical question, recommendations, background, objectives, explanations, and references. This revision was intended to collect up-to-date international evidence. The highlights of this revision are to (1) newly specify costs and conflicts of interest; (2) describe the clinical significance of pelvic lymph node dissection and para-aortic lymphadenectomy, including variant histologic types; (3) describe more clearly the indications for laparoscopic surgery as the standard treatment; (4) provide guidelines for post-treatment hormone replacement therapy; (5) clearly differentiate treatment of advanced or recurrent cancer between the initial treatment and the treatment carried out after the primary operation; (6) collectively describe fertility-sparing therapy for both atypical endometrial hyperplasia and endometrioid adenocarcinoma (corresponding to G1) and newly describe relapse therapy after fertility-preserving treatment; and (7) newly describe the treatment of trophoblastic disease. Overall, the objective of these guidelines is to clearly delineate the standard of care for uterine body neoplasms in Japan with the goal of ensuring a high standard of care for all Japanese women diagnosed with uterine body neoplasms.

Keywords

Clinical practice guidelines Endometrial cancer Treatment Trophoblastic disease Uterine sarcoma 

Notes

Acknowledgments

We thank the Japan Society of Obstetrics and Gynecology, the Japan Association of Obstetricians and Gynecologists, the Japanese Gynecologic Oncology Group, the Japan Society of Clinical Oncology, and the Japanese Society for Therapeutic Radiology and Oncology for their comments and contributions throughout the project. We also acknowledge the support by grants from the Ministry of Health, Labour and Welfare and H24-Clinical Cancer Research-001 (chief researcher, Koichi Hirata).

Members of guidelines formulation committee Yasuhiko Ebina, Hisaya Fujiwara, Shinji Fukunaga, Yasuyuki Hasuo, Atsushi Hongo, Kazuhiko Ino, Yuko Kaneyasu, Hidenori Kato, Naoki Kawamura, Yoichi Kobayashi, Kaneyuki Kubushiro, Masataka Kudo, Hideo Matsui, Koji Matsumoto, Yoshiki Mikami, Toshinari Muramatsu, Shoji Nagao, Satoru Nagase, Takafumi Nakamura, Toru Nakanishi, Satoru Nakayama, Hideyuki Ohtake, Yoshikazu Ozaki, Nobuyuki Susumu, Tsutomu Tabata, Kiyoshi Takamatsu, Masashi Takano, Satoshi Takeuchi, Yoshito Terai, Takafumi Toita, Akiko Tozawa, Takashi Uno, Hidemichi Watari, Tetsuro Yahata, Hideko Yamamoto, Koji Yamazawa, Nozomu Yanaihara, Masami Yasuda, Yoshihito Yokoyama.

Members of guidelines evaluation committee Daisuke Aoki, Yoichi Aoki, Makoto Emoto, Takayuki Enomoto, Toru Hachisuga, Seiryu Kamoi, Takahiro Kasamatsu, Noriyuki Katsumata, Junzo Kigawa, Hiroaki Kobayashi, Takeshi Kodaira, Junichi Kodama, Shinichi Komiyama, Hiroyuki Kuramoto, Makoto Kuroda, Masaki Mandai, Etsuko Miyagi, Takashi Nakano, Kaei Nasu, Fumitaka Numa, Kazunori Ochiai, Tsuyoshi Saito, Toshiaki Saito, Masaru Sakamoto, Noriaki Sakuragi, Nobuhiro Takeshima, Toshimitsu Toya, Satoshi Umezawa, Yoh Watanabe, Hiroyuki Yanai.

Compliance with ethical standards

Conflict of interest

Kiyoshi Takamatsu received lecture fees from Bayer Yakuhin, Ldt, and Pfizer Japan Inc.

References

  1. 1.
    Matsuda A, Matsuda T, Shibata A et al (2014) Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 44(4):388–396CrossRefGoogle Scholar
  2. 2.
    For act on anti-cancer measures based on the data of statistics white paper 2012 (Shinoharashinsha Publishers Inc.) Cancer Information Service, National Cancer Center, JapanGoogle Scholar
  3. 3.
    Nagase S, Katabuchi H, Hiura M et al (2010) Evidence-based guidelines for treatment of uterine body neoplasmin Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition. Int J Clin Oncol 15:531–542CrossRefPubMedGoogle Scholar
  4. 4.
    Ariyoshi H (2002) Guideline for correct use of antineoplastic agents (draft). General theory. Gan To Kagaku Ryoho 29(6):970–977 (in Japanese) PubMedGoogle Scholar
  5. 5.
    Ochiai K, Okamoto A, Katsumata N (2002) Guidelines for proper use of antineoplastic agents. Gynecologic cancer. Gan To Kagaku Ryoho 29(6):1047–1054 (in Japanese) PubMedGoogle Scholar
  6. 6.
    Fukui T, Yoshida M, Yamaguchi N (2007) Minds clinical practice guideline. Igaku-Shoin, Tokyo, p 40 (in Japanese)Google Scholar
  7. 7.
    Dowdy SC, Mariani A, Lurain JR (2012) Uterine cancer. In: Berek JS (ed) Berek and Novak’s gynecology, 15th edn. Lippincot Williams & Wilkins, Philadelphia, PA, pp 1250−1303Google Scholar
  8. 8.
    Miller DS, Creasman WT (2012) Adenocarcinoma of the uterine corpus. In: DiSaia PJ, Creasman WT (eds) Clinical gynecologic oncology, 8th edn. Elsevier Saunders, Philadelphia, pp 141–174Google Scholar

Copyright information

© Japan Society of Clinical Oncology 2016

Authors and Affiliations

  • Yasuhiko Ebina
    • 1
    Email author
  • Hidetaka Katabuchi
    • 2
  • Mikio Mikami
    • 3
  • Satoru Nagase
    • 4
  • Nobuo Yaegashi
    • 5
  • Yasuhiro Udagawa
    • 6
  • Hidenori Kato
    • 7
  • Kaneyuki Kubushiro
    • 8
  • Kiyoshi Takamatsu
    • 9
  • Kazuhiko Ino
    • 10
  • Hiroyuki Yoshikawa
    • 11
  1. 1.Department of Obstetrics and GynecologyKobe University Graduate School of MedicineKobeJapan
  2. 2.Department of Obstetrics and Gynecology, Faculty of Life SciencesKumamoto UniversityKumamotoJapan
  3. 3.Department of Obstetrics and GynecologyTokai University School of MedicineIseharaJapan
  4. 4.Department of Obstetrics and GynecologyYamagata University Faculty of MedicineYamagataJapan
  5. 5.Department of Obstetrics and GynecologyTohoku University Graduate School of MedicineSendaiJapan
  6. 6.Fujita Health University School of MedicineToyoakeJapan
  7. 7.Division of Gynecologic OncologyNational Hospital Organization, Hokkaido Cancer CenterSapporoJapan
  8. 8.Department of Obstetrics and GynecologyToho University School of Medicine, Toho University Medical Center Ohashi HospitalTokyoJapan
  9. 9.Department of Obstetrics and GynecologyTokyo Dental College Ichikawa General HospitalIchikawaJapan
  10. 10.Department of Obstetrics and GynecologyWakayama Medical UniversityWakayamaJapan
  11. 11.Department of Obstetrics and Gynecology, Faculty of MedicineUniversity of TsukubaTsukubaJapan

Personalised recommendations